• Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy.
Auteur:Casneuf, Veerle F; Demetter, Pieter; Boterberg, Tom; Delrue, Louke; Peeters, Marc; Van Damme, Nancy
Informations sur la publication:Oncology Reports, 22, 1, page (105-113)
Statut de publication:Publié, 2009-07
Sujet CREF:Anatomopathologie
Médecine pathologie humaine
MeSH keywords:Angiogenesis Inhibitors -- administration & dosage
Antigens, CD95 -- metabolism
Antimetabolites, Antineoplastic -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- pharmacology
Apoptosis -- drug effects
Caspase 3 -- metabolism
Cell Line, Tumor
Chemotherapy, Adjuvant
Deoxycytidine -- administration & dosage -- analogs & derivatives
Epidermal Growth Factor -- metabolism
Indoles -- administration & dosage
Microvessels -- drug effects
Neovascularization, Pathologic -- drug therapy -- enzymology -- pathology
Pancreatic Neoplasms -- blood supply -- drug therapy -- enzymology -- pathology -- radiotherapy
Pregnancy Proteins -- metabolism
Protein Kinase Inhibitors -- administration & dosage
Pyrroles -- administration & dosage
Radiotherapy, Adjuvant
Time Factors
Vascular Endothelial Growth Factor A -- metabolism
Note générale:Comparative Study
Journal Article
Research Support, Non-U.S. Gov't